共 109 条
[1]
O’Connell MJ(1995)Efficacy of adjuvant fluorouracil and folinic acid in colon cancer Lancet. 345 939-944
[2]
Laurie JA(1998)Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer J Clin Oncol. 16 295-300
[3]
Kahn M(2010)Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials Ann Surg Oncol. 17 959-966
[4]
Wilkinson NW(2009)Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: cancer and leukemia group B protocol 89803 J Clin Oncol. 27 1814-1821
[5]
Yothers G(2008)Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy Clin Cancer Res. 14 1413-1417
[6]
Lopa S(2004)Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy Clin Cancer Res. 10 5880-5888
[7]
Bertagnolli MM(2011)Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer Int J Cancer. 128 1935-1945
[8]
Niedzwiecki D(2003)Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med. 349 247-257
[9]
Compton CC(2009)The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status Eur J Cancer. 45 365-373
[10]
Morris M(2001)P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma Clin Cancer Res. 7 1343-1349